AWS Health Innovation Podcast podcast

#81, Thinking Big to Improve Liver Disease Outcomes, Quin Wills from Ochre Bio

0:00
27:30
Spol 15 sekunder tilbage
Spol 15 sekunder frem
Quin Wills, Co-Founder & CSO of Ochre Bio, joins us to discuss their use of deep analysis of liver genetics and precision RNA design to develop new therapies for liver diseases like hepatitis, cirrhosis and liver cancer.

Flere episoder fra "AWS Health Innovation Podcast"